Yuwell Medical and Inogen, two of the world's leading manufacturers of oxygen concentrators, have announced a strategic investment agreement aimed at expanding their presence in the global respiratory and medical device industries. Through its wholly owned subsidiary, Yuwell (Hong Kong) Holdings, Yuwell has agreed to invest approximately $27.2 million in Inogen, securing a 9.9% stake in the company's outstanding common stock.

The partnership was officially revealed at Arab Health in Dubai, a major global healthcare exhibition and conference. This collaboration unites two key players in the respiratory health markets of China and the United States, establishing a strong foundation for long-term business synergy. The agreement encompasses multiple areas of cooperation, including international distribution, trademark licensing, joint research and development, and supply chain optimization.

Alex Wu, Chairman of Yuwell Medical, emphasized the company's vision for long-term growth, stating that Yuwell aims to become one of the top three global companies in the home medical health sector. He highlighted that working alongside international partners is essential for delivering competitive medical solutions and improving healthcare accessibility for patients worldwide. Wu stressed that the investment in Inogen is part of Yuwell’s broader strategy to enhance its global footprint and strengthen its expertise in respiratory healthcare.

The announcement took place at Arab Health, which is now in its 50th edition and has attracted participants from over 180 countries. The exhibition serves as a key platform for unveiling healthcare innovations and fostering collaborations within the industry. Alongside the exhibition, the Arab Health Congress has returned with nine continuing medical education (CME) conferences and three Healthcare Business Forums, showcasing the latest advancements in medical technology and business strategies.

This investment comes at a time when the global consumer healthcare market is experiencing rapid expansion. The growing demand for advanced medical devices, including oxygen concentrators, reflects the increasing focus on respiratory health solutions, particularly in response to aging populations and rising cases of chronic respiratory diseases worldwide.

By forming this strategic alliance, Yuwell and Inogen are positioning themselves to capitalize on the accelerating demand for high-quality respiratory care. Leveraging their combined expertise, the companies aim to drive innovation, improve supply chain efficiency, and expand access to life-enhancing oxygen therapy solutions across global markets. As the healthcare landscape continues to evolve, this collaboration marks a significant step toward meeting the growing medical needs of patients worldwide.